Logo
x

Search category

Subscribe Now

Prevention

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

  • June 24, 2021
Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

  • June 24, 2021
AstraZeneca's AZD7442 Fails to Meet its Primary Endpoint in P-III STORM CHASER Study for the Prevention of Symptomatic COVID-19

AstraZeneca's AZD7442 Fails to Meet its Primary Endpoint in P-III STORM CHASER Study for the Prevention of Symptomatic COVID-19

  • June 15, 2021
AstraZeneca's AZD7442 Fails to Meet its Primary Endpoint in P-III STORM CHASER Study for the Prevention of Symptomatic COVID-19

AstraZeneca's AZD7442 Fails to Meet its Primary Endpoint in P-III STORM CHASER Study for the Prevention of Symptomatic COVID-19

  • June 15, 2021
Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue

Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue

  • March 26, 2021
Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue

Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue

  • March 26, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.